FindTrial
Sign In

A comparative study of 2% 1mg/kg iv lignocaine versus 2% 2mg/kg nebulized lignocaine for hemodynamic response during scopy

A comparative study of 2 percentage 1mg/kg iv lignocaine versus 2 percentage 2mg/kg nebulized lignocaine for hemodynamic response during laryngoscopy - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/097907
Enrollment
150
Registered
2025-11-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: Iv lignocaine and neb lignocaine: 2%1mg/kg iv lignocaine Intervention2: 2 percent lignocaine iv and nebulized: 2 percent 1mg/kg iv lignocaine and 2 percent 2mg/kg nebulized lignocaine C

Sponsors

Gujarat Adani institute of medical scieneces
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients between aged 18-60 years having ASA grade 1 and 2 posted for elective surgery under general anaesthesia. Mallampati grade 1 and 2

Exclusion criteria

Exclusion criteria: Patient refusal Respiratory or cardiac dysfunction Renal or liver impairment

Design outcomes

Primary

MeasureTime frame
Hemodynamic response to laryngoscopyTimepoint: 0min, 1min,3min,5min—

Secondary

MeasureTime frame
NilTimepoint: Nil—

Countries

India

Contacts

Public ContactDr Mandakinee Thacker

Gujarat Adani institute of medical scieneces

mandakinee.thacker@gamis.ac.in9925007046

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026